发明名称 High drug load immediate and modified release oral dosage formulations of eprosartan used to block angiotensin II (AII) receptors in the treatment of hypertension, congestive heart failure and renal failure
摘要 A high drug load granulation of (E)-á-[2-n-butyl-1- [(4-carboxyphenyl) methyl]-1H- imidazol-5-yl] methylene-2- thiophenepropionic acid in the anhydrous form, and a process for its production is described. Compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure are also described. Figures 1 (A), 2 (A) and 3 (A) show, respectively, the thermogravimetric analysis (TGA), the differential scanning calorimetric (DSC) thermogram and the powder X-ray diffraction (XRD) pattern of the free base of anhydrous (E) -á-2-n-butyl-1- [ (4-carboxyphenyl) methyl]-IH-imidazol-5-yl] methylene-2-thiophenepropionic acid.
申请公布号 NZ504565(A) 申请公布日期 2002.11.26
申请号 NZ19980504565 申请日期 1998.11.17
申请人 SMITHKLINE BEECHAM CORPORATION 发明人 VENKATESH, GOPADI M
分类号 A61K9/14;A61K9/16;A61K9/20;A61K31/4178;A61P9/00;A61P9/12;A61P13/12;A61P43/00;(IPC1-7):A61K9/14;A01N43/50;A61K9/22 主分类号 A61K9/14
代理机构 代理人
主权项
地址